ArticleCancers2021

Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial.

Renaud Sabatier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.